SomaLogic UK
Research Grant Award

Overview

SomaLogic is pleased to announce the very first UK Research Grant award using the SomaScan 11K Assay. One winner will receive high-plex proteomic data from 40 human plasma or serum samples, and two runners-up will receive 50% and 25% discounts, respectively. All analyses will be performed using the new SomaScan 11K Assay, enabling an unprecedented 11,000 protein measurements in plasma and serum samples.

Program details

The goal of this grant award is to assist researchers in the UK to generate pilot data for future grant applications and to promote use of the SomaScan 11K Assay as an essential tool for high quality proteomic data.

Applicants are invited to write a short proposal of 500 words or less, outlining their pilot research project, by 29 March 2024. Proposals will be reviewed within four weeks of the submission close date (29 March 2024).

A committee formed of SomaLogic staff will review and select the winning proposals based on the
following criteria:

• The overall application completeness
• Did the applicant have an original proposal with clear goals and outcomes
• Provide a clear approach and design which matches the goals and outcomes
• How the protein data and analysis are intended to be used
• What are the next steps the researcher intends to take with this additional knowledge
• How does SomaScan 11K Assay data increase insight into health and disease for their given focus area?

Winners

One winner will be awarded a fully funded project to analyze 40 samples of their choice. The two runners-up will receive either a 50% or 25% discount for the analysis of 40 samples. All samples will be processed on the SomaScan 11K Assay, together with upstream and downstream support from SomaLogic (including discussions with Technical Support to validate study design and analytical considerations – and with the project management team to arrange sample shipment and downstream bioinformatic support), excluding shipment costs to SomaLogic’s CLIA-certified lab at U.S. World Headquarters or at a SomaLogic Authorized Site. Samples must be submitted by 26 June 2024 and can only be human serum or plasma.

If applicants have any questions about sample submission requirements, they should contact us here.

Eligibility criteria

1. 1. The grant program terms and conditions apply and are available here.
   2. The grant is only open to researchers who are based in the United Kingdom and based at an institution or group where they perform the research.
   3. All submissions must be in English and comply with the criteria outlined here in this guide.
   4. The samples processed on the SomaScan 11K Assay need to be available and meet certain criteria (Handling and Processing Guide, available here).
   5. Pilot studies which are creative, bring new insight to health and disease, and have potential to lead to longer term studies are considered highly.
   6. For questions about your eligibility or to ask questions about the study you have proposed, please contact us through the form linked to at the bottom of this page.
   7. Only one application per person is allowed.
   8. Project samples submitted must be either plasma or serum.